Back to Journals » Drug Design, Development and Therapy » Volume 14

Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway [Corrigendum]

Authors Zhou X , Wu X, Qin L, Lu S, Zhang H, Wei J, Chen L, Jiang L, Wu Y, Chen C, Huang R

Received 5 August 2020

Accepted for publication 5 August 2020

Published 28 October 2020 Volume 2020:14 Pages 4575—4577

DOI https://doi.org/10.2147/DDDT.S275618



Zhou X, Wu X, Qin L, et al. Drug Des Devel Ther. 2020;14:2667–2684.


The authors have advised when preparing the images for Figure 5A on page 2675, the incorrect image was used for the 0 h DMDD H group. This inadvertently led to the duplication of images for the DMDD M group and DMDD H group. The correct Figure 5 is shown below. 

 

The authors have also advised the incorrect image was used for Figure 14C on page 2682 which inadvertently led to the duplication of images for RAF1 in Figure 14A and GAPDH in Figure 14C. The correct Figure 14 is shown below.


The authors apologize for these errors and advise they do not affect the results of the paper.

 

Read the original article

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.